The Government of Canada is committed to advancing the development of new treatments and tools with the potential to save lives, improve health outcomes, and strengthen Canada's capacity for future innovation. To make sure health products in Canada are safe and effective, they must first be evaluated through clinical trials.
That is why today, the Honourable Mark Holland, Minister of Health, announced that the Government of Canada is investing more than $43 million to support 14 new clinical trials focused on preparing Canada to respond to future health emergencies and advancing the country's life sciences sector.
The 14 clinical trials will assess treatments, diagnostic tests, and prevention tools for a wide range of health concerns including the flu, sepsis, stroke, tuberculosis, antimicrobial resistance, hepatitis C, COVID-19, and pneumonia.
These trials are being supported by the Canadian Institutes of Health Research (CIHR) Clinical Trials Fund, an important part of Canada's Biomanufacturing and Life Sciences Strategy, and Canada's Strategy for Patient-Oriented Research.
The full list of clinical trials can be found here: CIHR Clinical Trials Projects
